Cargando…

miR-600 inhibits lung cancer via downregulating the expression of METTL3

BACKGROUND: Methyltransferase like 3 (METTL3) is an RNA methyltransferase implicated in mRNA biogenesis, decay, and translation control through N(6)-methyladenosine (m(6)A) modification. METHODS: To find new treatment strategies for lung cancer and to elucidate the mechanism underlying the phenomeno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Wenwen, Huo, Baosheng, Shi, Xiulan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362936/ https://www.ncbi.nlm.nih.gov/pubmed/30774445 http://dx.doi.org/10.2147/CMAR.S181058

Ejemplares similares

Downregulation of hsa-miR-30b-3p Inhibits the Oncogenicity of Lung Adenocarcinoma by Targeting the METTL7B Gene
por: Li, Ning, et al.
Publicado: (2022)

miR-519d downregulates LEP expression to inhibit preeclampsia development
por: Cai, Hairui, et al.
Publicado: (2021)

MiR-208b Regulates the Conversion of Skeletal Muscle Fiber Types by Inhibiting Mettl8 Expression
por: Li, Xiang, et al.
Publicado: (2022)

miR-212-5p inhibits nasopharyngeal carcinoma progression by targeting METTL3
por: Zhou, Hongyu, et al.
Publicado: (2022)

Retraction to “miR-519d downregulates LEP expression to inhibit preeclampsia development”
por: Cai, Hairui, et al.
Publicado: (2022)

miR-101 inhibits glioma cell invasion via the downregulation of COX-2
por: Ma, Chunyang, et al.
Publicado: (2016)

Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl
por: Paccez, Juliano D., et al.
Publicado: (2019)

Downregulation of circRNA_100876 Inhibited Progression of NSCLC In Vitro via Targeting miR-636
por: Song, Jianxiang, et al.
Publicado: (2020)

Downregulation of KIAA1199 by miR‐486‐5p suppresses tumorigenesis in lung cancer
por: Wang, Anqi, et al.
Publicado: (2020)

MS‐275 potentiates the effect of YM‐155 in lung adenocarcinoma via survivin downregulation induced by miR‐138 and miR‐195
por: Luo, Bai‐Ling, et al.
Publicado: (2019)

Echinacoside Suppresses the Progression of Breast Cancer by Downregulating the Expression of miR-4306 and miR-4508
por: Bian, Peng, et al.
Publicado: (2021)

miR-181a Inhibits Cervical Cancer Development via Downregulating GRP78
por: Luo, Chengyan, et al.
Publicado: (2017)

Downregulation of miR-7-5p Inhibits the Tumorigenesis of Esophagus Cancer via Targeting KLF4
por: Shi, Woda, et al.
Publicado: (2020)

Sinomenine Inhibits Migration and Invasion of Human Lung Cancer Cell through Downregulating Expression of miR-21 and MMPs
por: Shen, Kun-Hung, et al.
Publicado: (2020)

MiR‐103‐3p targets the m(6)A methyltransferase METTL14 to inhibit osteoblastic bone formation
por: Sun, Zhongyang, et al.
Publicado: (2021)

miR-183 inhibits the metastasis of osteosarcoma via downregulation of the expression of Ezrin in F5M2 cells
por: ZHAO, HAIEN, et al.
Publicado: (2012)

MiR‐17‐3p inhibits osteoblast differentiation by downregulating Sox6 expression
por: Chen, Nan, et al.
Publicado: (2020)

Downregulation of miR-1-3p expression inhibits the hypertrophy and mineralization of chondrocytes in DDH
por: Ding, Rui, et al.
Publicado: (2021)

miR-96 suppresses renal cell carcinoma invasion via downregulation of Ezrin expression
por: Yu, Nengwang, et al.
Publicado: (2015)

miR-202 Suppresses Hepatocellular Carcinoma Progression via Downregulating BCL2 Expression
por: Zhuang, Donghai, et al.
Publicado: (2020)

RUNX3-regulated circRNA METTL3 inhibits colorectal cancer proliferation and metastasis via miR-107/PER3 axis
por: Zhang, Feng, et al.
Publicado: (2022)

MiR-200c downregulates HIF-1α and inhibits migration of lung cancer cells
por: Byun, Yuree, et al.
Publicado: (2019)

Silencing of KCNK15-AS1 inhibits lung cancer cell proliferation via upregulation of miR-202 and miR-370
por: Peng, Jun, et al.
Publicado: (2019)

Downregulated miR-18a and miR-92a synergistically suppress non-small cell lung cancer via targeting Sprouty 4
por: Zhang, Xinju, et al.
Publicado: (2022)

miR-145 downregulates the expression of cyclin-dependent kinase 6 in human cervical carcinoma cells
por: ZHANG, JING, et al.
Publicado: (2014)

Aberrant Expression of miR-362 Promotes Lung Cancer Metastasis through Downregulation of Sema3A
por: Luo, Dan, et al.
Publicado: (2018)

METTL3 Promotes Osteo/Odontogenic Differentiation of Stem Cells by Inhibiting miR-196b-5p Maturation
por: Han, Xiao, et al.
Publicado: (2023)

Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway
por: Peng, Wen, et al.
Publicado: (2019)

METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing
por: Chen, Xiaoxiang, et al.
Publicado: (2020)

METTL3 suppresses neuropathic pain via modulating N6-methyladenosine-dependent primary miR-150 processing
por: Zhang, Le, et al.
Publicado: (2022)

CREB Ameliorates Osteoarthritis Progression Through Regulating Chondrocytes Autophagy via the miR-373/METTL3/TFEB Axis
por: Zhang, Haibin, et al.
Publicado: (2022)

miR‐134 inhibits non‐small cell lung cancer growth by targeting the epidermal growth factor receptor
por: Qin, Qin, et al.
Publicado: (2016)

miR-548d-3p inhibits osteosarcoma by downregulating KRAS
por: Chen, Jianhua, et al.
Publicado: (2019)

Downregulation of MiR-30a is Associated with Poor Prognosis in Lung Cancer
por: Tang, Ruixue, et al.
Publicado: (2015)

miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression
por: Teng, Da, et al.
Publicado: (2022)

Downregulation of miR-16 via URGCP pathway contributes to glioma growth
por: Hong, Liang, et al.
Publicado: (2017)

miR‐33a inhibits cell growth in renal cancer by downregulation of MDM4 expression
por: Jiang, Kehua, et al.
Publicado: (2019)

miR-600 promotes ovarian cancer cells stemness, proliferation and metastasis via targeting KLF9
por: Shan, Lili, et al.
Publicado: (2022)

Ischemic postconditioning protects nonculprit coronary arteries against ischemia-reperfusion injury via downregulating miR-92a, miR-328 and miR-494
por: Wang, Jian, et al.
Publicado: (2022)

miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1
por: Tan, Wenliang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_burtitsag9rg122eg1d67be8kh